State lawmakers are considering expanding the types of obesity treatments covered by Nevada Medicaid, including approving ...

People who can't afford the name-brand drugs have been flocking to compounded versions, which are available at a fraction of ...

The future of American drug innovation is threatened by US regulations that permit knockoff versions of new drugs to be sold to US consumers.

Mounjaro, a tirzepatide drug prescribed for diabetes, could help people without this condition lose 13% of their body weight ...

The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...

Large-scale compounding facilities have to stop making tirzepatide, the main ingredient in blockbuster obesity drug Zepbound, Wednesday.

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

Here is a link to watch the earliest episodes of Donald Trump’s mid-aughts reality show, “The Apprentice,” now streaming on ...

A new study suggests blockbuster weight loss drugs Wegovy and Zepbound are not cost-effective at their current prices, despite the proven health benefits. The study, published in JAMA Health Forum and ...

Jim Cramer recently talked about the market selloff and how years of profits are lost within days when panic hits the market: ...

For decades, the United States has led the world in pharmaceutical innovation -- developing drugs that combat cancer, heart disease, AIDS, diabetes and other ...

Even a little weight loss can work wonders for your health. A study found that people at high risk for developing type 2 diabetes who lost 5-7% of their weight had a 58% lower risk of developing it.